Advertisement

Topics

Good News on Early Breast Cancer: Herceptin Treatment Can Be Shortened

18:02 EDT 16 May 2018 | The New York Times News

A large, new study shows that the treatment regimen, typically recommended for a year, can be just as effective at 6 months, reducing serious side effects and costs.

Original Article: Good News on Early Breast Cancer: Herceptin Treatment Can Be Shortened

NEXT ARTICLE

More From BioPortfolio on "Good News on Early Breast Cancer: Herceptin Treatment Can Be Shortened"

Advertisement
Quick Search
Advertisement
Advertisement